select trial semaglutide cardiovascular outcomes without diabetes 2023 From drugs... to weight loss drugs... to cardiometabolic drugs? The may mark the beginning of that transition. Where do you think GLP-1 receptor agonists will stand 10 years from Cardiovascular outcomes of semaglutide and

Speaker: Brett Allen Slack (Politecnico di Milano) 341 Breaking through data monopolies: AI, open data, and transparency for just urban planning In an era of global challenges and crises, multi-spatial and multi-temporal data have become essential for the effective monitoring of urban change and the evaluation of policy success across administrative boundaries

NSAID-Induced Gut Damage Long-term NSAID use can erode the stomach lining and small intestine, leading to pain, bleeding, and poor nutrient absorption

Interestingly, as shown in our transcriptome data, in addition to the pronounced enrichment of genes associated with JA signaling in systemic leaf tissues after GSH treatment, genes responsive to other defense phytohormones such as ethylene and salicylic acid, which are responsible for plant resistance to pathogen infection, are also highly upregulated (Supplementary Data 1), implying that GSH might also act as a signaling molecule to activate the plant systemic immune response

Long-Term Use The long-term safety profile remains unclear due to limited clinical studies (muscleandbrawn.com)